John Wiley & Sons (WLY) still looks attractive for Magic Formula investors because the market continues to price it like a slow-growing legacy publisher, while the underlying company is a mostly digital research and learning franchise with recurring revenue, solid cash generation, a covered dividend, meaningful share repurchases, and enough balance-sheet flexibility to keep investing in higher-quality assets. MagicDiligence gives WLY a Pass rating, and the stock has also shown positive relative strength versus the market over the past six months.

Why The Market Stays Skeptical

The skepticism is easy to see. Wiley is a 200-year-old publisher, reported revenue fell to $1.68 billion in fiscal 2025 from just over $2.0 billion two years earlier, Learning still has soft spots, and the Emerald deal raises the usual questions about leverage and integration. AI licensing adds another layer of doubt because investors are right to ask how repeatable that revenue really is.

But the headline decline overstates the damage. Wiley spent the last two years selling non-core operations such as University Services, Wiley Edge, and CrossKnowledge, so a meaningful part of the ugly revenue and earnings history reflects portfolio cleanup rather than decay in the continuing research franchise.

What Wiley Actually Owns

Wiley is now mostly a digital research business, not a print publisher in slow motion. In fiscal 2025, 83% of adjusted revenue came from digital products and services and 48% came from recurring or highly predictable sources. Research generated about $1.08 billion of revenue, versus about $585 million for Learning, and in the January 2026 quarter about 88% of Research Publishing revenue came from journal subscriptions, transformational agreements, and open access.

That matters because research journals and workflow tools are sticky. Wiley publishes more than 1,800 journals, works with scientific and professional societies, runs infrastructure such as Wiley Online Library and Atypon, and increasingly licenses authoritative content into AI and data products. Emerald fits that same pattern: Wiley agreed in June 2026 to buy Emerald for about GBP 337 million, or roughly $452 million, adding a business expected to generate more than $85 million of 2026 revenue, with 92% recurring subscription revenue and about $30 million of cost savings within three years.

What The Numbers Still Say

The best way to get Wiley wrong is to confuse cleanup with deterioration. Fiscal 2025 reported revenue fell 10%, but adjusted revenue excluding sold businesses rose 3%. Research revenue rose 3% to $1.075 billion, Learning rose 2% to $584.8 million, and operating income jumped to $221.4 million from $52.3 million. Adjusted EBITDA margin improved to 24% from 22.8%.

The momentum carried into fiscal 2026. In the January quarter, revenue rose 1.5% to $410 million and operating income rose 21% to $62.7 million. For the first nine months of fiscal 2026, operating cash flow rose to $103.3 million from $52.3 million, while free cash flow less product development spending improved to $55.5 million from negative $1.2 million. Management still expects about $200 million of free cash flow for the full year.

That cash flow is large relative to the stock. Local screen data shows WLY around $44.17 with a market cap near $2.28 billion, implying an equity free-cash-flow yield of roughly 8.8% on management's 2026 target. The annualized dividend of $1.42 per share yields a bit over 3%, and Wiley repurchased about $70 million of stock in the first nine months of fiscal 2026. As of January 31, 2026, the company had about $807.5 million of debt, $95.1 million of cash, net leverage of 1.7x trailing EBITDA, and roughly $485 million of unused borrowing capacity. That is not a pristine balance sheet, especially after Emerald, but it is also not the profile of a business under stress.

Why The Valuation Still Looks Too Low

This is the missing part of the story. At about $44.17 per share, Wiley is trading for only about 10.7x the midpoint of management's fiscal 2026 adjusted EPS guidance of $3.90 to $4.35. Macrotrends puts the stock at about 9.8x trailing earnings as of June 12, 2026. That is cheap not only against the S&P 500, which Multpl shows at roughly 32x trailing earnings, but also against much of Wiley's own cleaner history, when the stock often traded in the low-to-high teens earnings multiple range.

The same point shows up on cash flow and enterprise value. Using management's roughly $200 million free-cash-flow target for fiscal 2026, the stock is valued at only about 11x free cash flow. Using the current market cap plus net debt of roughly $712 million at January 31, 2026, Wiley's enterprise value is about $3.0 billion. Against management's fiscal 2026 EBITDA margin target of 25.5% to 26.5% on revenue expected around $1.67 billion, that works out to only about 7x forward EBITDA.

Those are the kinds of multiples investors usually assign to businesses with serious cyclicality, balance-sheet stress, or clear structural decline. Wiley does have risks, but it does not look like that kind of business. Research revenue is sticky, cash generation is improving, the dividend is supported, and buybacks are active. Even the AI angle is not being valued like a growth premium. Right now it looks more like free optionality layered onto a stock already priced like a no-growth asset.

What Could Still Go Wrong

The clearest operating risk is that Learning stays weak longer than expected. Through the first nine months of fiscal 2026, Learning revenue fell 7% and Professional fell 9%, pressured by soft retail and weaker consumer and corporate spending. If that drags on, margin gains elsewhere will have to do more of the work.

AI adds both upside and risk. Publishers Weekly reported $40 million of AI licensing revenue in fiscal 2025, and Wiley said AI revenue was about $42 million year-to-date by the third quarter of fiscal 2026. That helps the thesis, but some of it may be lumpy, and The Bookseller highlighted unease around AI-rights deals and the lack of an opt-out for authors in at least one arrangement. Investors also still have to watch subscription-agent risk, foreign exchange, China exposure in research output, and Emerald integration.

Current WLY read Value
MagicDiligence verdict Pass
Momentum read Positive 6M vs SPY
Why it screens Recurring research revenue, improving margins, and strong free-cash-flow potential
Main bull point The market is still pricing Wiley like a legacy publisher instead of a digital research franchise with real cash generation
Main risk Learning softness, AI monetization uncertainty, and Emerald integration could turn a clean rerating story into a slower grind

Wiley does not need to become a high-multiple AI winner to work from here. It only needs the research franchise to keep compounding recurring revenue, the cost structure to stay tighter, and free cash flow to remain stronger than the market expects. If that happens, the current valuation still looks modest.

If you want to compare WLY with the rest of the current shortlist, go back to the current MagicDiligence screen results.

References